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Abstract  
 
COVID-19 may impact on tuberculosis (TB) diagnosis and care. We analysed a city-wide electronic TB 
register in Blantyre, Malawi and interviewed TB officers. Malawi had no official “lockdown” but closed 
schools and borders on 23
-
March 2020.  In interrupted time series analysis, there was an immediate 
35.9% reduction in TB notifications (95% CI 22.0 to 47.3%) in April, which recovered to near pre-
pandemic numbers by December 2020, but with 333 (95% CI 291 to 375) fewer cumulative 
notifications than anticipated. Women and girls were impacted (30.7% fewer cases, 95% CI 28.4 to 
33.0%) more than men and boys (20.9% fewer, 95% CI 18.5 to 23.3). Fear of COVID-19 infection, 
temporary facility closure, inadequate protective equipment and COVID-19 stigma with similar 
presenting symptoms to TB were mentioned. Public health measures could benefit both TB and 
COVID-19, but only if diagnostic services remain accessible and are considered safe to attend. 
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Introduction 
 
Tuberculosis (TB) is a major killer, with approximately 1.4 million deaths annually (1) making it second 
only to COVID-19 as the biggest cause of infectious deaths in 2020.(2) 
 
As well as the direct health effects of COVID-19, the secondary effects of the COVID-19 pandemic—
including lockdowns, economic turmoil, healthcare worker illness and attrition, overwhelmed health 
facilities and fear of healthcare facilities—may impact on delivery of health services.(3)  Concerns have 
been raised that COVID-19 may adversely impact on TB disease diagnosis, treatment and prevention, 
reversing recent progress in improving TB case detection and mortality, although physical distancing 
measures for COVID-19 could also reduce TB transmission.(1,3)  Initial modelling, published in May 
2020, suggested that healthcare service disruption worldwide could lead to 6.3 million additional cases 
of TB and an additional 1.4 million TB deaths between 2020 and 2025 due to under-diagnosis of TB 
and TB treatment interruptions.(4)  Empirical data from high TB burden settings is urgently needed to 
better understand the impact of COVID-19 on TB, and to inform mitigation strategies. 
 
Malawi is one of thirty high TB/HIV burden countries.(1)  In Blantyre, located in the Southern Region 
Malawi, a citywide electronic TB register has been maintained in partnership by Malawi Liverpool 
Wellcome Trust, the Malawian National TB Programme, and Blantyre District Health Office.(5) We 
used these data to investigate the impact of COVID-19 on citywide TB case notifications.  We 
hypothesised that the direct and indirect effects of COVID-19 epidemic in Malawi would reduce TB 
case notifications and this may have been disproportionately experienced at different health system 
levels and by certain population groups, including people living with HIV.  Our primary objective was 
to estimate the number of missed TB case notifications, and our secondary objective was to determine 
whether this was affected by sex, health facility or HIV status. Finally, in order to investigate and 
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explain the underlying causes of under-notification of TB, we undertook a qualitative study with TB 





To estimate population denominators for Blantyre District, we obtained age- and sex-specific 
background mortality rates and fertility rates from 2008-2020 World Population Prospect (WPP) data 
(6) and  used the Cohort-Component method to combine them into local estimates from the 2008 and 
2018 Malawi National population censuses. 
 
In Blantyre, TB Officers working at all primary health centres and the city’s main central hospital 
(Queen Elizabeth Central Hospital [QECH]) record demographic and clinical characteristics of all TB 
patients who register for treatment using an electronic case record form. Data collected includes date 
and clinic of registration, age, sex and HIV status, residential address, and TB characteristics 
(pulmonary vs. extra-pulmonary and microbiological classification). Records are reconciled with 
Ministry of Health National TB Programme treatment registers every quarter. Each month, a randomly-
selected 5% sample of registered TB cases undergo home tracing for data validation purposes.  
 
Statistical modelling 
To investigate the impact of COVID-19 on TB case notification in Blantyre we conducted an 
interrupted time series analysis. (7)  The Malawi Government declared a state of emergency due to 
COVID-19 on the 23
rd
 March 2020, and the first COVID-19 cases were diagnosed on 2
nd
 April 2020.  
We assumed that implementation of COVID-19 restrictions and the government and public response to 
the emerging epidemic would cause both an immediate “step change” change in TB case notifications 
and a “slope change” leading to different month-by-month trends than seen pre-COVID.(7) Using a 
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negative binomial distribution to account for overdispersion, we modelled monthly counts of TB cases 
as a function of month, COVID-19, and month-given-COVID (Model 1). We used notification data 
from June 2016, as this marks the start of Malawi introducing “test and treat” for antiretroviral therapy 
(ART) provision and the implementation of Xpert for TB diagnosis. 
 
Model 1: 
 	 ~                       	  
Where cases=expected numbers of notified TB cases per month,  =intercept, covid=indicator variable 
for period before or after introduction of COVID restrictions (before or after 1
st
 April 2020), 
month=indicator for month from June 2016, and population=monthly updated population denominator 
for Blantyre District 
 
We estimated trends in TB case notification rates (CNRs) by converting model-fitted monthly numbers 
of notified cases to annualised equivalent cases per 100,000 population using estimated Blantyre census 
population denominators.  We used the model to predict TB CNRs from April 2020 onwards under the 
counterfactual situation where COVID had not occurred and background trends (i.e. trend from April 
2016 and March 2020) had continued linearly.  We defined numbers of “missed” TB cases as the 
difference between the observed numbers of notified cases and numbers expected under the 
counterfactual no-COVID-19 situation (acknowledging that some of the “missed” cases may be 
diagnosed later and so be delayed rather than entirely missed). Ninety-five percent confidence intervals 
for the total number of “missed” TB cases were estimated through 1,000 parametric bootstrap 
replications. Observed cases are taken as is and predicted cases under the counterfactual are from a 
normal distribution (on the link scale) with mean equal to model prediction for given month under the 
counterfactual and standard deviation equal to model standard error for predictions for the given month 
under the counterfactual. 
 
For the secondary objective, we modelled the differential impact of COVID on TB case notifications by 
sex, HIV status and whether TB was diagnosed at the Central Hospital or primary care level (Model 2).  
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Because there was a small amount of missing data for HIV status and sex, we preformed multiple 
imputation using chained equations with predictive mean matching, using the R ‘mice’ package.(8)  
 
Sensitivity analysis 
TB exhibits seasonality related to climate and weather conditions.(9) We therefore performed a 
sensitivity analysis by adding seasonal effects to the interrupted time series model using a harmonic 
term with two peaks every 12 months. 
 
Qualitative analysis 
Between 21 October and 14 December 2020, in-depth interviews were conducted with 12 TB Officers 
from the Blantyre Health Facilities (2 from QECH, and 10 from primary health care centers) to gain an 
understanding of the main reasons for the changes in TB case notifications in the COVID-19 era. A 
local social scientist with experience of qualitative interviewing conducted interviews in Chichewa. 
Data were recorded and simultaneously transcribed and translated to English. A thematic framework 
was developed from the initial four interviews and applied across all subsequent interviews. Coding and 
data analysis were done using NVIVO. Interviews were continued until saturation of themes was 
reached.  
 
Ethical approval  
Participants provided oral consent for their data to be recorded in the enhanced surveillance dataset; a 
waiver of requirement for written consent was approved by London School of Hygiene and Tropical 
Medicine and College of Medicine, University of Malawi, both of whom provided ethical approval for 
the Blantyre enhanced TB surveillance system and qualitative interviews. Participants in the in-depth 
interviews provided informed written consent. 
 
Role of funding source and data availability 
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The Blantyre Enhanced TB Surveillance data is funded by Wellcome, through a grant to ELC 
(200901/Z/16/Z). Wellcome had no role in design or conduct or this work, or the decision to publish. 





Interrupted time series 
Between June 2016 and December 2020, 10,274 TB cases were notified in Blantyre.  Between June 
2016 and March 2020 (i.e. before COVID), annualised Blantyre TB CNRs fell by approximately 1% per 
month, with a peak of 405 cases per 100,000 people in November 2016, declining to 137 cases per 
100,000 people in October 2019.  A total of 9,199 people with TB were notified in Blantyre during this 
period: 3,561 among women and girls and 5,611 in men and boys (27 missing sex).  People living with 
HIV represented 5,820 (63.3%) TB notifications and HIV-negative people made up 3,279 (35.6%) of 
the notified people with TB (100 people with missing or unknown HIV status).  TB notifications were 
split fairly evenly between QECH (4,889 notifications, 53.1%) and primary health facilities (4,310 
notifications, 46.9%).  Children (aged ≤ 14 years old) comprised 920 (10%) of notifications.  The 
median (interquartile range) age among adults diagnosed with TB was 35 (28 - 44) years for women and 
37 (30 - 45) years for men. 
 
The declaration of a national COVID-19 disaster led to an abrupt decline in TB notifications in April 
2020 by 35.9% (95% CI 22.1 to 47.3%) – Figure 1.  However, subsequently, TB notifications increased 
at a rate of 4.40% per month (0.59 to 8.36%).  The effect of this initial decline at the start of the COVID 
pandemic was that observed Blantyre TB annualised CNRs in March 2020 (pre-COVID-19) and April 
2020 (post COVID-19) were 240 and 152 cases per 100,000 people, respectively.  This compares to a 
predicted April CNR of 230 cases per 100,000 person years in the counterfactual scenario with no 
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COVID.  However, by November and December 2020 observed Blantyre TB CNRs were 205 and 156 
cases per 100,000 person-years, compared to a predicted CNR of 213 and 211 cases per 100,000 in the 
counterfactual scenario with no COVID. 
 
Figure 1: Impact of COVID-19 on TB monthly tuberculosis case notification rate in Blantyre, 
Malawi 
Dots = observed number of cases. Line = fitted model (95% CI) with both step and slope change due to 
COVID, see methods for details. Shaded areas indicate time that COVID emergency was declared in 
Malawi 
 
Between April 2020 and December 2020, 1,075 cases of TB were notified in Blantyre (equivalent to 
196 cases per 100,000 person-years) – Table 1.  Under the counterfactual situation of no COVID-19 
epidemic, we would have expected that 1,408 people with TB would have been notified (95% CI 1,366 
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to 1,451 cases, equivalent to annualised case notification rate of 221 cases per 100,000 people).  We 
therefore estimate that the COVID epidemic (directly and indirectly) led to 333 fewer TB notifications 
(95% CI 291 to 376), equivalent to a 23.7% reduction in TB notifications (95% CI 21.4 to 26.0%). 
 
Table 1: Modelled impact of COVID-19 on Blantyre TB case notifications between April 2020 and 

















Model 1     
Overall 1075 
1408 
(1366 to 1451) 
333 
(291 to 376) 
23.7 
(21.4 to 26.0) 
Model 2     
Male 692 875 (848 to 901) 183 (156 to 209) 20.9 (18.5 to 23.3) 
Female 383 553 (534 to 571) 170 (151 to 188) 30.7 (28.4 to 33.0) 
Primary health centres 488 761 (737 to 785) 273 (249 to 297) 35.9 (33.9 to 37.9) 
Queen Elizabeth 
Central Hospital 
587 666 (645 to 688) 79 (58 to 101) 11.9 (9.10 to 14.7) 
HIV-positive 660 820 (796 to 845) 160 (136 to 185) 19.6 (17.2 to 219) 
HIV-negative 415 607 (586 to 627) 192 (171 to 212) 31.6 (29.3 to 33.8) 
 
As a secondary objective, we modelled which population groups were most affected by disruption to TB 
services (Figure 2).  This model incorporates sex, HIV status and healthcare facility (QECH vs. primary 
care clinics), and estimates slightly higher numbers of missed TB notifications (352, 95% CI 319 to 
385) between April to December 2020.  Men and boys accounted for a slightly larger number of missed 
TB diagnoses with 183 fewer notification (95% CI 158 to 209) compared to 170 fewer notifcations 
among women and girls (95% CI 151 to 188). However, women and girls had a larger proportional 
decline than men and boys (30.7%, 95% CI: 28.4 to 33.0%; compared to 20.9%, 95% CI 18.5 to 
23.3%).  Notifications at Primary healthcare clinics were also disproportionately reduced compared to 
hospital notifications, as were notifications for HIV-negative patients compared to those among people 
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Figure 2: Impact of COVID-19 on TB case notifications in Blantyre, Malawi by HIV status, 
registration site and sex 
Dots = observed number of cases per month. Line = fitted model (95% CI) with both step and slope 
change due to COVID, see methods for details. Vertical lines indicate time that COVID emergency was 
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Of the 12 in-depth interviews with health providers, nine participants were female, and three were male, 
with ages ranginh from 34 to 53 years.  Ten had secondary-level education. 
 
Themes that emerged from the in-depth interviews related to both an overall reduction in people 
attending health facilities and to a reduction in quality of TB services provided. Reduced attendance 
affecting all services at health facilities were said to reflect a combination of fear among general public 
of getting infected with COVID-19 if they attended the facility (fear of contagion), closures related to 
disinfection following health-worker diagnosis with COVID-19 and health-worker strikes, and COVID-
19 prevention measures such as face masks and social distancing that lead to reduced capacity at any 
given clinic and hence access to care. TB specific issues included the overlap between common TB 
symptoms and symptoms of COVID-19.  Fearfulness among general clinic and TB service staff together 
with initial shortages in PPE left providers unable to support sputum submission for TB testing, so that 
people with those symptoms were instead turned away from facilities lacking personal protective 
equipment (PPE). 
 
Reduced attendance at health facilities 
As well as reduced attendance from fear of becoming infected with COVID-19 among the general 
public, several health workers tested positive for COVID-19 during the epidemic (quote 1 & quote 2, 
Table 2).  These facility based COVID-19 outbreaks led to  temporary facility closure for disinfection. 
This not only affected numbers attending the health facilities on the days of closure but also led to 
greater fear of infection there and in one instance rumours that the clinic was closed for a longer period 
of time (quote 3, Table 2).  Finrally, strikes and ‘sit-ins’ over both risk allowance payments and lack of 
(PPE) also resulted in temporary closures of facilities (quote 4 – quote 6, Table 2) 
 
Regulations about facemasks and public transport 
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Government COVID-19 prevention measures on face masks and social distancing requirements were 
also reported to have contributed to reduced access to health services. Mandatory use of face masks at 
health facilities was introduced during the epidemic, but TB officers cited the inability to afford a mask 
and the feeling that masks “suffocate them” as reasons for patients not wanting to wearing one (quote 7, 
Table 2). Patients who tried to attend facilities without having a mask were “sent back” (meaning that 
they were not seen by a healthworker) and often did not return (quote 8, Table 2).  Public transportation 
in Blantyre also had a limit on vehicle capacity, which led to doubled transport costs, limiting clinic 
access (quote 9, Table 2). 
 
TB specific issues 
Since the presenting symptoms for TB and COVID-19 are very similar (both cough and fever), TB 
officers reported this led to particular issues around TB testing. Firstly, people with these symptoms 
were reportedly afraid of being tested for COVID-19 if they attended the facilities. TB Officers said 
they were more afraid of COVID-19 than TB because they knew that TB could be cured (quote 10 & 
quote 11, Table 2) and also that patients with COVID-19 may need to be placed under facility isolation 
(quote 12, Table 2).  This similarity of symptoms also led to people who would normally have been 
tested for TB being turned away from the facility and told to instead “go home and call the COVID help 
line” (quote 13, Table 2).  
 
The TB officers themselves also spoke of their own fear of contracting COVID-19 infection from 
presumptive TB patients, given the similarity of symptoms. They changed how they interacted with 
symptomatic people, including interacting less directly, and not supervising sputum collection as closely 
(quote 14 & quote 15, Table 2). In addition, a lack of personal protective equipment in health facilities 
was also reported to have forced most TB officers to temporarily stop conducting TB tests or 
supervising sputum collection at all. For those patients who did submit sputum results could be delayed 
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due to fears of laboratory staff that the sputum may contain high levels of COVID-19 (quote 16, Table 
2).  
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“People were afraid of getting infected if they come to the facility.“ 
– IDI Participant 02, Female  
 
“… they were afraid saying that if the workers are found with COVID, so if we go there they 
will infect us” 























“…they were told that the clinic had been shut down and people are not being assisted… 
which means people were just staying in their homes and the TB was just being spread 
amongst them.” 
 – IDI Participant 03, Female 
 
“Our facility wasn’t closed, but there was a certain week that we were just going but we were 
not working because there was no PPE, so people were afraid. There were no gloves, no masks 
how were we going to work? So a sit-in happened. “ 
– IDI Participant 02, Female 
 
“Yes we had a strike at this hospital and the strike occurred in all health centres. The reason 
behind the strike was that COVID-19 was at its peak but we didn’t had PPE which was putting 
us at risk” 
– IDI Participant 05, Female 
 
“The first strike was against shortage of PPEs and the second strike was organized by Interns 
who were complaining that they are making them work on this dangerous disease of COVID-
19 yet they are not being employed… And the other strike was about risk allowance” 




















“…then government announced that wearing of mask is mandatory some people who couldn’t 
manage wear the mask were making a decision of not going to the hospital instead, some were 
complaining that they suffocate in a mask.”  
– IDI Participant 04, Female 
 
“…all patients should be wearing masks when coming here but some patients were ignoring 
and when we send them back to go and get a mask some patients were ending up not coming 
back” 
– IDI Participant 08, Female 
 
“Some people travel from far communities to come here and the increase in transport fare also 
influenced some people to fail to come to the hospital” 
– IDI Participant 08, Female 
Similarity 







“… sometimes they think that if they test positive [for COVID-19], people will discriminate 
them, they have fear of unknown. So during this period people weren’t coming to say I have a 
cough test me, they were just staying at home buying Bactrim and drinking it at home.“ 
– IDI Participant 02, Female  
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“the signs and symptoms of COVID-19 and TB were somehow similar so because the signs 
were similar people were scared to come to the hospital because they were assuming that 
instead of testing them for TB we will test the for COVID-19” 
– IDI Participant 06, Female  
 
“They were communicating that if a person has fever then that is a sign of COVID-19 and that 
particular person is required to go into isolation so people were afraid to come to the hospital 
when they have fever because of the messages that they may be isolated with their families” 
– IDI Participant 07, Male 
 
“… they were expecting that someone who has COVID-19 coughs and sneezes severely, and 
has fever and headaches, so when they ask about those, the same things that a TB patient 
presents, that was when those people were being sent back to go home and call the COVID-19 
help line.”  



















“… we were no longer asking many questions once the person tells us that she has dry cough 
we were running away from that person… Because if the person has dry cough the first thing 
that we were thinking of is COVID-19” 
–  IDI Participant 05, Female 
 
“I was scared because it was difficult to know if the patient is coughing because of TB or 
COVID-19.” 
– IDI Participant 11, Female 
 
“… in the laboratory… the ones that are involved in the testing, they were refusing to handle 
sputum because they were taught that sputum has the highest concentration of COVID-19 so 
some were dodging which was resulting in delays” 





As well as directly causing millions of deaths, the COVID-19 pandemic has directly and indirectly 
impacted on delivery of health services throughout the globe.(10) In this analysis of the impact of the 
COVID-19 pandemic on TB notifications in Blantyre Malawi, we found a substantial immediate decline 
in TB case notifications concurrent with the start of the COVID-19 pandemic in Malawi.  This is 
consistent with initial reports on COVID impact from other settings.(11–18) However, we show that 
following the initial decline, TB case notification rates then increased and reached near pre-pandemic 
levels within nine months.  Overall, we estimate that there were 333 fewer cases of TB notified 
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(equivalent to 39 per 100,0000 people) from April 2020 to December 2020 than would have been 
expected if there was no COVID-19 epidemic. For the affected individuals these missed or delayed 
diagnoses are likely to have severe consequences, and for public health programmes the consequences 
might hinder progress towards eliminating TB.  The TB case notifications may also be indicative of 
more general disruption of a range of primary healthcare services. 
 
To put these results into context, Malawi is a high HIV/ TB burden country.  Estimated prevalence of 
TB in urban Malawi was 988 per 100,000 people at the last national survey in 2013.(19) TB in Malawi 
is declining, due to concerted efforts from the national and District TB and the HIV programmes. Test 
and treat for HIV (i.e. starting antiretroviral therapy regardless of CD4 cell count) was introduced in 
Malawi in June 2016 and Malawi is coming close to achieving UNAIDS HIV 90-90-90 goals.  
However, TB remains one of the leading causes of death and years of life lost in Malawi. 
 
We consider that the major reason for the drop in notifications is that people with true TB disease had 
their TB diagnosis missed, or at least delayed. This is consistent with data from our qualitative 
interventions with TB officers, who noted that—in the immediate period after the start of the Malawi 
COVID-19 epidemic—access to health facilities was extremely challenging.  Alternative explanations 
are that people were diagnosed with TB and started on treatment but not notified to the national 
programme, or that the true incidence of TB declined.  We consider these explanations unlikely. TB 
treatment cannot be accessed in Malawi outside of TB registration centres, and our electronic TB 
surveillance system is cross-referenced with paper ledgers that confirm the same trends in notifications.  
Reduced incidence of other respiratory pathogens, notably influenza, have resulted from the non-
pharmaceutical interventions for COVID-19, and it is possible that TB transmission has also declined.  
However, the prolonged interval between infection and onset of symptoms for TB makes an immediate 
impact on notifications within three months implausible, particularly as Malawi has had less stringent 
COVID-19 prevention measures than many other countries.  
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Our qualitative interviews indicate that in addition to general restrictions on healthcare access during the 
COVID-19 epidemic TB testing and notifications were particularly affected due to the similarity in 
presenting symptoms between TB and COVID-19. Not only were people with TB symptoms less likely 
to attend facilities for fear of COVID-19 diagnosis and possible consequences such as isolation, but 
those who did attend were likely to be turned away and directed to COVID-19 specific services where 
they would be unlikely to be assessed for TB. In high TB burden countries alignment of COVID-19 and 
TB diagnosis, prevention and care is likely to lead to improved outcomes for both diseases.  
 
Women had disproportionately higher reductions in case notifications than men, as did HIV-negative 
compared to HIV-positive patients, and notifications from primary care clinics compared to the central 
hospital. We hypothesise that women faced greater barriers to accessing healthcare during COVID than 
men, possibly due to greater requirements to home-school children, or social gender norms meaning that 
men were more likely to disregard COVID-19 public health restrictions, and perhaps additionally due to 
economic requirements to leave the house to work.(20)   
 
Primary healthcare centres were more affected than the central hospital, both in terms of initial step 
change (drop in TB cases notified at the start of COVID-19) and with slower recovery in the period after 
COVID-19 Reasons for this could include the central hospital being prioritised for personal protective 
equipment and so remaining more fully functional.  Patients diagnosed with TB at the hospital tend to 
have more severe illness, and so potentially were unable to delay healthcare seeking.  TB cases among 
HIV negative people declined more than among people living with HIV.  This could be associated with 
site of TB diagnosis: the central hospital has the by far largest number of HIV-positive people registered 
for ART in the city.  Alternatively, PLHIV may have more severe TB symptoms and be less able to 
defer healthcare seeking.   
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Limitations to this work include uncertainty around the counterfactual conditions; between June 2016 
and March 2020 TB case notifications were declining and for the counterfactual “no COVID” scenario 
we modelled them as continuing to decline at the same rate. Since December 2020, Malawi has had a 
second wave of COVID-19.  Whilst our electronic enhanced surveillance data is entered in real time, 
data is monitored and verified on a quarterly basis, so we do not yet have information on the impact of 
the COVID-19 second wave in Malawi.  
 
Malawi is also fortunate to have well-functioning TB and HIV programmes that may be more resilient 
to COVID-19 than in other countries.  Malawi did not introduce any substantial restrictions on 
population movement and gathering due to COVID-19, so there have been no legal restrictions on 
travelling to TB clinics.  Therefore, our data are not necessarily generalisable to other settings in 
Southern Africa or elsewhere. 
 
The individual and household impact of missed or delayed TB diagnoses are likely to be severe for the 
affected people. However, it is relatively reassuring that the initial COVID-19 related decline in TB case 
notification was not sustained and that the Malawi TB programme had a relatively quick recovery once 
COVID-19 first wave rescinded.  We observed a shorter period of disruption that earlier modelling of 
COVID-19 impact on TB assumed.(4)  It is neither possible nor desirable to consider either COVID-19 
or TB diagnosis, treatment, care and public health measures in isolation.  Rather there may be 
opportunities to combine resources to tackle both COVID-19 and TB, through improved infection 
prevention and control at health facilities, strengthened laboratory infrastructure and community 
engagement to address stigma and provide sources of information about both diseases, in a setting of 
universal health coverage. 
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